• Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer Quick View
    • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer Quick View
    • ,

    • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer

    • Hertinib-40mg (Neratinib) is an advanced oral medication specifically designed to treat early-stage HER2-positive breast cancer in patients who have completed prior trastuzumab-based therapy. As a targeted therapy, Hertinib-40mg works by inhibiting the HER2 protein, which is responsible for the growth and spread of cancer cells. By blocking this protein, Hertinib-40mg helps prevent cancer from returning, offering patients improved outcomes and…
    • Read more